Next Generation Allogeneic CAR-T Cell Therapies for Hematologic Malignancies
Time: 2:30 pm
day: Day 1 – Track B – Afternoon
Details:
• Next-generation genome editing platform to develop allogeneic CAR-T cell therapies
• Implementation of armouring strategies to promote CAR-T cell persistence
